Omeros (OMER) Current Taxes (2021 - 2026)

Omeros (OMER) posted Current Taxes of $1.1 million for Q1 2026, little changed sequentially from $1.1 million in Q4 2025.

Omeros (OMER) Current Taxes (2021 - 2026) Analysis & Trends

Omeros has reported Current Taxes for 6 years, with the latest figure at $1.1 million in Q1 2026.

Quarterly Current Taxes changed N/A year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (changed N/A YoY) and the FY2025 annual result came in at $1.1 million, up 1983.64% from the prior year.
Current Taxes was little changed at $1.1 million in Q1 2026 per OMER's latest filing, from $1.1 million in the prior quarter.
Over five years, Current Taxes peaked at $4.9 million in Q4 2022 and troughed at $55000.0 in Q4 2024.
A 5-year average of $2.1 million and a median of $1.2 million in 2023 frame the typical range for Current Taxes.
The sharpest annual moves came in 2022 and 2025: Current Taxes soared 1341.12% in 2022, then soared 1983.64% in 2025.
Over 5 years, Current Taxes stood at $4.9 million in 2022, then plunged by 74.79% to $1.2 million in 2023, then sank by 95.52% to $55000.0 in 2024, then jumped by 1983.64% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
According to Business Quant data, Current Taxes over the past three periods registered $1.1 million, $1.1 million, and $55000.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	49.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	76.32 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	59,089.99
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Omeros	1.24 Bn	1.24 Bn	27.73 Mn	656,000.00

Download Data